UNIGE document Scientific Article
previous document  unige:93754  next document
add to browser collection
Title

Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non-Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial
Authors
Gautschi, Oliver
Rothschild, Sacha I
Li, Qiyu
Matter-Walstra, Klazien
Zippelius, Alfred
Betticher, Daniel C
Früh, Martin
Stahel, Rolf A
show hidden authors show all authors [1 - 18]
Published in Clinical Lung Cancer. 2017, vol. 18, no. 3, p. 303-309
Abstract Pemetrexed and bevacizumab as single agents have been approved for maintenance therapy after platinum-based induction in patients with advanced nonsquamous non-small-cell lung cancer. It is currently unknown whether bevacizumab plus pemetrexed is superior to pemetrexed alone.
Keywords Bevacizumab — Chemotherapy — Lung cancer — Maintenance therapy — Pemetrexed
Identifiers
PMID: 27993482
Full text
Article (Author postprint) (598 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Faculté de médecine / Section de médecine clinique / Département de chirurgie
Research group Mésothéliome pleural malin (944)
Citation
(ISO format) 		GAUTSCHI, Oliver et al. Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non-Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial. In: Clinical Lung Cancer, 2017, vol. 18, n° 3, p. 303-309. https://archive-ouverte.unige.ch/unige:93754

123 hits

0 download

Contact an author

Update request

Update

Deposited on : 2017-04-21

Export document
Format :
Citation style :